Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 176   

Articles published

GSK 1,462.45 -19.05 (-1.29%)
price chart
After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be ...
shire With Abbvie's �53.20 per share offer receiving a 'thumbs up' from the board of Shire (LSE: SHP), it means that shares in the healthcare stock have risen by 75% during the course of 2014.
Related articles »  
3 Things That Say GlaxoSmithKline plc Is A Buy
Well, having the company in the Fool's Beginners' Portfolio, reckon I can say it's cheap! Here are three things that would make me add GlaxoSmithKline if it wasn't already there: 1. Fundamentals. Quality companies are often rated on higher-than-average ...
Here' Why Investors Ditched GlaxoSmithKline plc (ADR) (NYSE:GSK) And ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) lost 5.98% on Wednesday after the U.K.'s biggest drugmaker reduced its forecast for the year, as sales of its best-selling asthma drug, Advair, continue to fall.
Related articles »  
Is Hikma Pharmaceuticals Plc A Better Buy Than GlaxoSmithKline plc Or Shire ...
shire It's been a great first half of 2014 for investors in Hikma (LSE: HIK), with the pharmaceutical company seeing its share price rise by 47%, while the FTSE 100 is up just 1.5%.
Why GlaxoSmithKline (GSK) Stock Is Falling Today
"We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
GlaxoSmithKline plc Given Hold Rating at Panmure Gordon (GSK)
GlaxoSmithKline plc (ADR) logo Panmure Gordon reiterated their hold rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research report sent to investors on Friday morning.
GlaxoSmithKline plc's �Underperform� Rating Reaffirmed at Credit Suisse (GSK)
Shares of GlaxoSmithKline plc (NYSE:GSK) traded up 1.21% during mid-day trading on Friday, hitting $53.72. 1,973,737 shares of the company's stock traded hands.
GlaxoSmithKline plc Receives Consensus Rating of �Hold� from Analysts (NYSE ...  Mideast Time
Related articles »  
Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And ...
Meanwhile, stable mate GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) continues to deal with negative publicity surrounding its Chinese operations, thereby holding its share price back throughout 2014 so that it is now down 1% for the year.
Related articles »  
Why The Chinese Corruption Saga Makes GlaxoSmithKline plc A Dicey Pick
Make no mistake: GlaxoSmithKline's ongoing bribery saga in China shows no signs of disappearing any time soon. Allegations initially emerged in June last year that the company was operating a vast slush fund to bribe doctors with cash and other ...
GSK's Mark Reilly In Another Scandal, This Time Over Sex Tape  Bidness Etc
China says GSK-linked trial being handled according to law  Reuters UK
Related articles »  
Heavy Volume And Pre-Market Movement For GlaxoSmithKline (GSK)
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide.